Edinburgh-based Craneware, a software firm that specializes in the US healthcare market, said in a trading update for the year ended June 30, 2017, that it expects to report full year revenue growth of 16% to $57.8 million and to deliver EBITDA of $18 million, up from $15.9m.

Craneware CEO Keith Neilson said: “We are delighted to confirm ongoing double digit growth and the first product sales on our new cloud-based platform, Trisus.

“The need to drive value in healthcare, and the challenges this brings, remains a universal topic of focus.

“We believe the innovation in Trisus positions us firmly at the forefront of an expanding market opportunity as the long term shift in US healthcare to value-based care and increased consumerism continues unabated.

“The ongoing investment in the Trisus platform and our Cost Analytics solutions continue to help customers improve margins so they can invest in quality patient outcomes.

“This growing market opportunity, combined with our ongoing profitable growth and strong cash position, provide management with confidence in its ability to deliver stakeholder value, at the same time as investing in our future.”

Craneware will announce its full year results on September 5.